-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

703A.O2.6 703. Cellular Immunotherapies: Basic and Translational: Overcoming Challenges in CAR-T Therapies Through Biological Insights

Symposia: Cellular Immunotherapies: Basic and Translational Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Translational Research
Saturday, December 9, 2023: 9:30 AM-11:00 AM
Room 6DE (San Diego Convention Center)
Moderators:
Melody Smith, MD, MS, Stanford University and Brian G Till, ARRAY(0xff53f98)
Disclosures:
Smith: BMS: Consultancy; A28: Membership on an entity's Board of Directors or advisory committees. Till: Mustang Bio: Consultancy, Patents & Royalties, Research Funding; BMS/Juno Therapeutics: Research Funding; Proteios Technology: Consultancy, Current holder of stock options in a privately-held company.
9:30 AM

Shinpei Harada1*, Daigo Hashimoto, MD, PhD2, Yumika Saito, MD3*, Toru Miyajima, MD3*, Wenyu Li3*, Hajime Senjo, MD4, Zixuan Zhang3*, Ryo Kikuchi3*, Masahiro Chiba3*, Hiroyuki Ohigashi3*, Takahide Ara, MD, PhD3*, Masao Nakagawa, MD, PhD3 and Takanori Teshima, M.D., Ph.D.3

1Department of Hematology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo City, Japan
2Hokkaido University Hospital, Sapporo, Japan
3Department of Hematology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo, Japan
4Department of Hematology, Hokkaido University, Kita-Ku, Japan

9:45 AM

Taisuke Kondo, PhD1, François Bourassa2*, Sooraj Achar, B.S.3*, Justyn DuSold1*, Pablo Cespedes4*, Madison Wahlsten, B.S.5*, Audun Kvalvaag4*, Guillaume Gaud6*, Paul Love, MD, PhD7*, Michael Dustin, PhD8*, Gregoire Altan-Bonnet, Ph.D.3*, Paul François2* and Naomi Taylor, M.D., Ph.D.9

1Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD
2Université de Montréal, Montréal, Canada
3National Cancer Institute, Bethesda, MD
4University of Oxford, Oxford, United Kingdom
5National Cancer Institute, Bethesda
6Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda
7NICHD/NIH, Bethesda, MD
8The Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom
9Pediatric Oncology Branch, National Institutes of Health, Bethesda, MD

10:00 AM

Stefanie Bachl, MD1,2*, Alexis Talbot, MD1,2*, Carter Ching1,2*, Nupura Kale1,2*, Zhongmei Li2*, Morgan Diolaiti, PhD3*, Amy Peixin Chen1,2*, Joseph Muldoon, PhD1,2*, Chang Liu1,2*, Thomas Martin, MD1,3, Justin Eyquem, PhD1,2,3,4,5* and Julia Carnevale, MD1,2,5*

1Department of Medicine, University of California, San Francisco, CA
2Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA
3UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
4Department of Microbiology and Immunology, University of California, San Francisco, CA
5Parker Institute for Cancer Immunotherapy, University of California, San Francisco, CA

10:15 AM

Janaki Manoja Vinnakota1*, Francesca Biavasco2*, Marius Schwabenland3*, Chintan Chhatbar4*, Rachael C Adams5,6,7*, Daniel Erny4*, Sandra Duquesne8*, Nadia El Khawanky9*, Henrike Salié10*, Dimitrios Athanassopoulos8*, Lukas Braun8,11*, Dominik Schmidt11,12*, Viktor Fetsch11*, Rebeka N. Javorniczky8*, Jenny N.H.G Ho8*, Reinhard Marks, MD13*, Ralph Wäsch, MD13, Federico Simonetta, MD, PhD14*, Geoffroy Andrieux15*, Dietmar Pfeifer, PhD16*, Gianni Monaco17,18*, Christian Capitini19*, Terry J. Fry, MD20, Thomas Blank4*, Bruce R Blazar, MD21, Eva-Maria Wagner Drouet22,23*, Matthias Theobald, MD23, Clemens Sommer24*, Matthias Stelljes, MD25, Christian Reicherts, MD26*, Astrid Jeibmann27*, Jens Schittenhelm28*, Camelia-Maria Monoranu29*, Andreas Rosenwald, MD30*, K. Martin Kortüm, MD31*, Leo Rasche, MD32*, Hermann Einsele33*, Philipp Tobias Meyer34*, Joachim Brumberg34*, Andreas Mackensen, MD35*, Michael von Bergwelt-Baildon, MD, PhD36*, Roland Coras37*, Nathalie L. Albert38,39*, Laura M. Bartos40*, Matthias Brendel40,41,42*, Adrien Holzgreve40*, Melanie Boerries, MD, PhD43,44*, Crystal L. Mackall, MD45, Justus Duyster, MD13*, Natalie Koehler, PhD46*, Felix Strübing47*, Bertram Bengsch48*, Marco Ruella, MD49, Marion Subklewe, MD50,51, Louisa von Baumgarten52*, Saar Gill, MD, PhD53,54, Marco Prinz, MD55,56,57* and Robert Zeiser, MD6,44,58

1Department of Medicine I - Medical centre - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany, University Medical Center Freiburg, Freiburg, Germany
2Department of Medicine1, Univeresity Medical Centre Freiburg, Freiburg, DEU
3Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, DEU
4Institute for Neuropathology, Medical Faculty, University of Freiburg, Germany, Freiburg, Germany
5QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
6Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany
7Faculty of Medicine, The University of Queensland, Brisbane, Australia
8Department of Medicine I - Medical centre - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany, Freiburg, Germany
96Department of Medicine III, School of Medicine, Technical University of Munich, Munich, Germany, Munich, Germany
10Department of Medicine II - Medical centre - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany, Freiburg, Germany
11Faculty of Biology, University of Freiburg, Freiburg, Germany
12University Medical Center Freiburg, Freiburg, DEU
13Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
14Division of Oncology and Hematology, University Hospital Geneve, Geneve, Switzerland
15Institute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, Germany, Freiburg, Germany
16University Clinics Medical Center, Freiburg, DEU
17Medical Center - University of Freiburg, Freiburg Im Breisgau, DEU
18Single-Cell Omics Platform Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany, Freiburg, Germany
19Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Bethesda
20CCR, NCI NIH, Aurora, CO
21Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN
22III. med. Klinik, Mainz, DEU
23Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany
24Institute of Neuropathology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany, Mainz, Germany
25Department of Internal Medicine A, University of Muenster, Muenster, Germany
26Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
27Institute of Neuropathology, University Hospital Münster, Münster, Germany, Muenster, Germany
28Department of Neuropathology, Institute of Pathology and Neuropathology, Eberhar, TüBingen, DEU
29Institute of Pathology, Wuerzburg, DEU
30Institute of Pathology, Julius-Maximilians-Universität Würzburg, Wuerzburg, Germany
31Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany, Würzburg, Germany
32Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
33Division of Hematology, University Hospital of Wurzburg, Wurzburg, Germany, WüRzburg, DEU
34Department of Nuclear Medicine - Medical centre - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany, Freiburg, Germany
35Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany
36Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
37Department of Neuropathology, University Hospital Erlangen, Erlangen, Germany, Erlangen, Germany
38Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany, Muncih, Germany
39German Cancer Consortium (DKTK), partner site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany, Munich, Germany
40Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany, Munich, Germany
41German Center for Neurodegenerative Diseases (DZNE), Munich, Germany, Munich, Germany
42Munich Cluster for Systems Neurology (SyNergy), Munich, Germany, Munich, Germany
43Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
44German Cancer Consortium (DKTK), Partner site Freiburg; and German Cancer Research Center (DKFZ), Heidelberg, Germany
45Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA
46Department of Internal Medicine III, Johannes Gutenberg-University Mainz, Mainz, Germany, Freiburg, Germany
47Center for Neuropathology and Prion Research, University Hospital, LMU Munich, Munich, Germany, Munich, Germany
48University Hospital Freiburg, Freiburg, DEU
49Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
50German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
51Department of Medicine III, LMU University Hospital, LMU Munich, Muenchen, Bavaria, Germany
52Division of Neuro-Oncology, Department of Neurosurgery, University Hospital, LMU Munich, Munich, Germany, Munich, Germany
53Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
54Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine, Philadelphia, PA
55Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, University of Freiburg, Freiburg, Germany
56Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany
57Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany
58University of Freiburg, CIBSS – Centre for Integrative Biological Signalling Studies, Freiburg im Bresigau, Germany

10:30 AM

Yongxian HU1*, Xia Li2,3*, Penglei Jiang4, Tingting Yang5*, Tianning Gu6*, Xiaohui Si, PhD7*, Yali Xie8*, Mingming Zhang9*, Guoqing Wei5*, Huijun Xu6*, Zenan Cen8*, Jiazhen Cui6*, Simao Huang6*, Fang Ni10*, Linqin Wang10*, Xiujian Wang, MD, PhD8*, Xiangjun Zeng11*, Delin Kong10*, Houli Zhao6*, Alex H. Chang12*, Yanlei Zhang13*, Jin Zhang14*, Jinyan Huang8*, Pengxu Qian, PhD15* and He Huang16*

1Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, HANGZHOU, China
2The First Affiliated Hospital, Zhejiang University School of Medicine, Hang zhou, China
3The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
4Institute of Hematology, Zhejiang University, Hangzhou, China
5Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
6Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
7The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, AL, China
8the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
9Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, Zhejiang, China
10The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, CHN
11The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., HANGZHOU, China
12Shanghai YaKe Biotechnology Ltd., Shanghai, China, Hangzhou, China
13Shanghai Yake Biotechnology Ltd., Shanghai, CHN
14Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
15Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China
16Bone Marrow Transplantation Center, Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, Hangzhou, China

10:45 AM

Ruchi P. Patel, MS1, Guido Ghilardi, MD1*, Yunlin Zhang, MS2*, Puneeth Guruprasad3*, Mathew G. Angelos, MD, PhD1, Raymone Pajarillo, MS2*, Khatuna Gabunia2*, Chong Xu2*, Tatiana Blanchard2*, John Scholler2*, Patrizia Porazzi, PhD2*, Gerald Linette, MD, PhD2*, Beatriz M. Carreno, PhD4* and Marco Ruella, MD1

1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
2Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
3Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, North Wales, PA
4Parker Institute for Cancer Immunotherapy and Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA

*signifies non-member of ASH